{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:52:37Z","timestamp":1776880357010,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-025-01385-7","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:25:30Z","timestamp":1748586330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Type 2 Diabetes Risk in Osteoporosis Patients Treated with Denosumab or Alendronate: A Nationwide Cohort Study"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-2515","authenticated-orcid":false,"given":"Kyoung Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-1865","authenticated-orcid":false,"given":"Seol A.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-6462","authenticated-orcid":false,"given":"Su Jin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-0258","authenticated-orcid":false,"given":"Gi Hyeon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8150-0266","authenticated-orcid":false,"given":"Kyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/978-981-13-3681-2_16","volume":"91","author":"TJ Aspray","year":"2019","unstructured":"Aspray TJ, Hill TR (2019) Osteoporosis and the ageing skeleton. Subcell Biochem 91:453\u2013476. https:\/\/doi.org\/10.1007\/978-981-13-3681-2_16","journal-title":"Subcell Biochem"},{"key":"1385_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40520-021-01817-y","volume":"33","author":"J Barnsley","year":"2021","unstructured":"Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M et al (2021) Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 33:759\u2013773. https:\/\/doi.org\/10.1007\/s40520-021-01817-y","journal-title":"Aging Clin Exp Res"},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276\u20131287. https:\/\/doi.org\/10.1016\/S0140-6736(10)62349-5","journal-title":"Lancet"},{"key":"1385_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bpobgyn.2013.02.005","volume":"27","author":"B Lunenfeld","year":"2013","unstructured":"Lunenfeld B, Stratton P (2013) The clinical consequences of an ageing world and preventive strategies. Best Pract Res Clin Obstet Gynaecol 27:643\u2013659. https:\/\/doi.org\/10.1016\/j.bpobgyn.2013.02.005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s13018-021-02821-8","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S et al (2021) Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16:669. https:\/\/doi.org\/10.1186\/s13018-021-02821-8","journal-title":"J Orthop Surg Res"},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3803\/EnM.2013.28.2.90","volume":"28","author":"YK Lee","year":"2013","unstructured":"Lee YK, Yoon BH, Koo KH (2013) Epidemiology of osteoporosis and osteoporotic fractures in South Korea. Endocrinol Metab 28:90\u201393. https:\/\/doi.org\/10.3803\/EnM.2013.28.2.90","journal-title":"Endocrinol Metab"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.11005\/jbm.2020.27.4.281","volume":"27","author":"SH Ahn","year":"2020","unstructured":"Ahn SH, Park SM, Park SY, Yoo JI, Jung HS, Nho JH et al (2020) Osteoporosis and osteoporotic fracture fact sheet in Korea. J Bone Metab 27:281\u2013290","journal-title":"J Bone Metab"},{"key":"1385_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.11005\/jbm.2020.27.4.281","volume":"16","author":"IR Reid","year":"2020","unstructured":"Reid IR (2020) A broader strategy for osteoporosis interventions. Nat Rev Endocrinol 16:333\u2013339. https:\/\/doi.org\/10.11005\/jbm.2020.27.4.281","journal-title":"Nat Rev Endocrinol"},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M22-1034","volume":"176","author":"A Qaseem","year":"2023","unstructured":"Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan T, Cooney TG et al (2023) Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Intern Med 176:224\u2013238. https:\/\/doi.org\/10.7326\/M22-1034","journal-title":"Ann Intern Med"},{"key":"1385_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6:598\u2013612. https:\/\/doi.org\/10.4239\/wjd.v6.i4.598","journal-title":"World J Diabetes"},{"key":"1385_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12889-021-10450-3","volume":"21","author":"SH Oh","year":"2021","unstructured":"Oh SH, Ku H, Park KS (2021) Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data. BMC Public Health 21:548. https:\/\/doi.org\/10.1186\/s12889-021-10450-3","journal-title":"BMC Public Health"},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4093\/dmj.2022.0106","volume":"46","author":"JH Bae","year":"2021","unstructured":"Bae JH, Han KD, Ko SH, Yang YS, Choi JH, Choi KM et al (2021) Diabetes fact sheet in Korea 2021. Diabetes Metab J 46:417\u2013426. https:\/\/doi.org\/10.4093\/dmj.2022.0106","journal-title":"Diabetes Metab J"},{"key":"1385_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7608964","author":"C Eller-Vainicher","year":"2020","unstructured":"Eller-Vainicher C, Cairoli E, Grassi G, Grassi F, Catalano A, Merlotti D et al (2020) Pathophysiology and management of type 2 diabetes mellitus bone fragility. J Diab Res. https:\/\/doi.org\/10.1155\/2020\/7608964","journal-title":"J Diab Res"},{"key":"1385_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00122","author":"C Cipriani","year":"2020","unstructured":"Cipriani C, Colangelo L, Santori R, Renella M, Mastrantonio M, Minisola S et al (2020) The interplay between bone and glucose metabolism. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2020.00122","journal-title":"Front Endocrinol"},{"key":"1385_CR15","doi-asserted-by":"publisher","first-page":"a031666","DOI":"10.1101\/cshperspect.a031666","volume":"8","author":"P Mera","year":"2018","unstructured":"Mera P, Ferron M, Mosialou I (2018) Regulation of energy metabolism by bone-derived hormones. Cold Spring Harb Perspect Med 8:a031666. https:\/\/doi.org\/10.1101\/cshperspect.a031666","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"1385_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s00198-011-1891-8","volume":"23","author":"JJ Body","year":"2012","unstructured":"Body JJ, Bergmann P, Boonen S, Devogelaer JP, Gielen E, Goemaere S et al (2012) Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporos Int 23(1):S1-23. https:\/\/doi.org\/10.1007\/s00198-011-1891-8","journal-title":"Osteoporos Int"},{"key":"1385_CR17","doi-asserted-by":"publisher","first-page":"e073435","DOI":"10.1136\/bmj-2022-073435","volume":"381","author":"H Lyu","year":"2023","unstructured":"Lyu H, Zhao SS, Zhang L, Wei J, Li X, Li H et al (2023) Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study. BMJ 381:e073435. https:\/\/doi.org\/10.1136\/bmj-2022-073435","journal-title":"BMJ"},{"key":"1385_CR18","doi-asserted-by":"publisher","first-page":"e2354734","DOI":"10.1001\/jamanetworkopen.2023.54734","volume":"7","author":"HK Huang","year":"2024","unstructured":"Huang HK, Chuang AT, Liao TC, Shao SC, Liu PP, Tu YK et al (2024) Denosumab and the risk of diabetes in patients treated for osteoporosis. JAMA Netw Open 7:e2354734. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.54734","journal-title":"JAMA Netw Open"},{"key":"1385_CR19","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1111\/dom.15708a","volume":"26","author":"AE Henney","year":"2024","unstructured":"Henney AE, Riley DR, O\u2019Connor B, Hydes TJ, Anson M, Zhao SS et al (2024) Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: n analysis of real-world, cohort data, with a systematic review and meta-analysis. Diabetes Obes Metab 26:3673\u20133683. https:\/\/doi.org\/10.1111\/dom.15708a","journal-title":"Diabetes Obes Metab"},{"key":"1385_CR20","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00198-024-07182-6","volume":"35","author":"W Rathmann","year":"2024","unstructured":"Rathmann W, Kostev K (2024) Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study. Osteoporos Int 35:2099\u20132106. https:\/\/doi.org\/10.1007\/s00198-024-07182-6","journal-title":"Osteoporos Int"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS (2017) Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 32:718\u2013728. https:\/\/doi.org\/10.3346\/jkms.2017.32.5.718","journal-title":"J Korean Med Sci"},{"key":"1385_CR22","doi-asserted-by":"publisher","first-page":"204201882311707","DOI":"10.1177\/20420188231170754","volume":"14","author":"B Xing","year":"2023","unstructured":"Xing B, Yu J, Zhang H, Li Y (2023) RANKL inhibition: a new target of treating diabetes mellitus? Ther Adv Endocrinol Metab 14:20420188231170750. https:\/\/doi.org\/10.1177\/20420188231170754","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1385_CR23","doi-asserted-by":"publisher","first-page":"e169317","DOI":"10.1172\/JCI169317","volume":"133","author":"N Bonnet","year":"2023","unstructured":"Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2023) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 133:e169317. https:\/\/doi.org\/10.1172\/JCI169317","journal-title":"J Clin Invest"},{"key":"1385_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB. Nat Med 11:183\u2013190. https:\/\/doi.org\/10.1038\/nm1166","journal-title":"Nat Med"},{"key":"1385_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","volume":"38","author":"M Calle","year":"2012","unstructured":"Calle M, Fernandez M (2012) Inflammation and type 2 diabetes. Diabetes Metab 38:183\u2013191. https:\/\/doi.org\/10.1016\/j.diabet.2011.11.006","journal-title":"Diabetes Metab"},{"key":"1385_CR26","doi-asserted-by":"publisher","first-page":"115268","DOI":"10.1016\/j.bone.2020.115268","volume":"134","author":"S Ferrari","year":"2020","unstructured":"Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A et al (2020) Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension. Bone 134:115268. https:\/\/doi.org\/10.1016\/j.bone.2020.115268","journal-title":"Bone"},{"key":"1385_CR27","doi-asserted-by":"publisher","first-page":"e2991","DOI":"10.1002\/dmrr.2991","volume":"34","author":"N Napoli","year":"2018","unstructured":"Napoli N, Pannacciulli N, Vittinghoff E, Crittenden D, Yun J, Wang A et al (2018) Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial. Diabetes Metab Res Rev 34:e2991. https:\/\/doi.org\/10.1002\/dmrr.2991","journal-title":"Diabetes Metab Res Rev"},{"key":"1385_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/21556660.2021.1989194","volume":"10","author":"BT Pacheco-Soto","year":"2021","unstructured":"Pacheco-Soto BT, Elguezabal-Rodelo RG, Porchia LM, Torres-Rasgado E, P\u00e9rez-Fuentes R, Gonzalez-Mejia ME (2021) Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis. J Drug Assess 10:97\u2013105. https:\/\/doi.org\/10.1080\/21556660.2021.1989194","journal-title":"J Drug Assess"},{"key":"1385_CR29","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/jbmr.1865","volume":"28","author":"AV Schwartz","year":"2013","unstructured":"Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LY et al (2013) Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res 28:1348\u20131354. https:\/\/doi.org\/10.1002\/jbmr.1865","journal-title":"J Bone Miner Res"},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765. https:\/\/doi.org\/10.1056\/NEJMoa0809493","journal-title":"N Engl J Med"},{"key":"1385_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(02)07451-2","volume":"359","author":"DA Grimes","year":"2002","unstructured":"Grimes DA, Schulz KF (2002) Bias and causal associations in observational research. Lancet 359:248\u2013252. https:\/\/doi.org\/10.1016\/S0140-6736(02)07451-2","journal-title":"Lancet"},{"key":"1385_CR32","doi-asserted-by":"publisher","first-page":"e0123279","DOI":"10.1371\/journal.pone.0123279","volume":"10","author":"DC Chan","year":"2015","unstructured":"Chan DC, Yang RS, Ho CH, Tsai YS, Wang JJ, Tsai KT (2015) The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus\u2014a population-based cohort study in Taiwan. PLoS ONE 10:e0123279. https:\/\/doi.org\/10.1371\/journal.pone.0123279","journal-title":"PLoS ONE"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"771426","DOI":"10.3389\/fendo.2021.771426","volume":"12","author":"R Viggers","year":"2021","unstructured":"Viggers R, Al-Mashhadi Z, Starup-Linde J, Vestergaard P (2021) Alendronate use and risk of type 2 diabetes: a Nationwide Danish nested case-control study. Front Endocrinol 12:771426. https:\/\/doi.org\/10.3389\/fendo.2021.771426","journal-title":"Front Endocrinol"},{"key":"1385_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","volume":"2","author":"JL Lund","year":"2015","unstructured":"Lund JL, Richardson DB, St\u00fcrmer T (2015) The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep 2:221\u2013228. https:\/\/doi.org\/10.1007\/s40471-015-0053-5","journal-title":"Curr Epidemiol Rep"},{"key":"1385_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4093\/dmj.2022.0375","volume":"47","author":"JH Baek","year":"2023","unstructured":"Baek JH, Park YM, Han KD, Moon MK, Choi JH, Ko SH (2023) Comparison of operational definition of type 2 diabetes mellitus based on data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey. Diabetes Metab J 47:201\u2013210. https:\/\/doi.org\/10.4093\/dmj.2022.0375","journal-title":"Diabetes Metab J"},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4093\/dmj.2021.0236","volume":"46","author":"HH Choi","year":"2022","unstructured":"Choi HH, Choi G, Yoon H, Ha KH, Kim DJ (2022) Rising incidence of diabetes in young adults in South Korea: a National Cohort Study. Diabetes Metab J 46:803\u2013807. https:\/\/doi.org\/10.4093\/dmj.2021.0236","journal-title":"Diabetes Metab J"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01385-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:21:18Z","timestamp":1766755278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01385-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01385-7","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KJ Kim, SA Jang, SJ Kwon, GH Seo, and KM Kim declares there are no conflicts of interest regarding this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Institutional Review Board of Yongin Severance Hospital, Yonsei University College of Medicine (IRB no. 9-2023-0114).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and complies with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. The protocol was approved by the Institutional Review Board of Yongin Severance Hospital, Yonsei University College of Medicine (IRB no. 9-2023-0114). Due to the retrospective nature of the study and anonymization of data, the requirement for informed consent was waived by the ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The requirement for informed consent was waived due to the anonymization of data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"78"}}